ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Elevated TRIM25 Impairs Poly (ADP-ribose) Metabolism via PARG Degradation and Mediates Compression-Induced Intervertebral Disc Degeneration.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Intervertebral disc degeneration (IVDD) is a leading global cause of low back pain, with abnormal mechanical stress being a central contributing factor. However, the molecular mechanisms through which mechanical stress signals are transduced into intracellular pathological responses to drive degeneration remain poorly understood. This study demonstrates that mechanical compression induces DNA damage and triggers parthanatos-a caspase-independent form of cell death driven by toxic accumulation of poly(ADP-ribose) (PAR) polymers. Mechanistically, mechanical compression upregulates the E3 ubiquitin ligase TRIM25, which directly binds to and promotes the ubiquitination and degradation of poly(ADP-ribose) glycohydrolase (PARG), leading to disrupted PAR metabolism and toxic PAR accumulation. Concurrently, TRIM25 targets the DNA repair protein Ku80 for degradation, exacerbating genomic instability and activating the RIG-I innate immune pathway, thereby inducing the release of inflammatory factors. Thus, under mechanical stress, TRIM25 acts as a key node coordinating DNA damage, cell death, and inflammatory responses, forming a multi-mechanistic network that promotes IVDD progression. In a rat model of compression-induced IVDD, restoring PAR homeostasis by targeting the TRIM25-PARG axis significantly attenuated disc degeneration, suggesting the therapeutic potential of targeting this pathway in IVDD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.